StoneX Group’s Inhibikase Therapeutics IKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,219
Closed -$12.1K 611
2022
Q3
$12.1K Buy
+2,219
New +$12.1K ﹤0.01% 296